The BPPV NICE CKS guidelines provide evidence-based recommendations for diagnosing and managing benign paroxysmal positional vertigo, a common inner ear disorder causing brief episodes of dizziness triggered by head movement. These guidelines, developed by the National Institute for Health and Care Excellence (NICE), standardize care across UK primary and secondary healthcare settings.
BPPV occurs when calcium carbonate crystals (otoliths) dislodge from the utricle into the semicircular canals, most often the posterior canal. This leads to abnormal fluid displacement during head motion, causing vertigo and nystagmus. The condition affects approximately 2% of the population annually, with higher prevalence in adults over 50.
Diagnosis relies on the Dix-Hallpike test, which induces characteristic geotropic nystagmus when the patient's head is positioned to stimulate the affected canal. A positive test confirms posterior canal BPPV. The NICE CKS guidelines emphasize using this test in primary care to avoid unnecessary referrals and imaging.
NICE CKS recommends that clinicians perform the Dix-Hallpike maneuver in a controlled setting. The patient lies supine with the head turned 45 degrees toward the affected side. Dizziness and torsional nystagmus lasting 10-30 seconds confirm the diagnosis. Symptoms typically resolve within minutes after returning to upright position.
If the test is positive, the guidelines recommend initiating the particle repositioning procedure (PRP), specifically the Epley maneuver. This involves a sequence of four head positions over 30-60 seconds each, designed to guide displaced otoconia out of the posterior canal and back into the utricle. Success rates exceed 80% after one session, according to a 2019 Cochrane review.
For patients who do not respond to PRP or have recurrent episodes, follow-up is advised. NICE recommends reassessment after 4 weeks. Persistent symptoms may require specialist referral to an ENT or neurotology clinic for further evaluation, especially if associated with hearing loss, tinnitus, or neurological signs.
The BPPV NICE CKS guidelines categorize interventions based on evidence strength and clinical context. The core treatment remains canalith repositioning maneuvers, with the Epley maneuver being the first-line option due to high efficacy and low risk.
| Intervention | Recommended Use | Evidence Level |
|---|---|---|
| Epley maneuver (PRP) | First-line for posterior canal BPPV | High (NICE, 2021) |
| Brandt-Daroff exercises | Home-based alternative for non-responsive cases | Moderate (Cochrane, 2019) |
| Medication (e.g., betahistine) | Not recommended for acute symptom relief | Low (NICE, 2021) |
Patients should be advised to avoid sudden head movements for 48 hours post-procedure. A 2020 study in the British Journal of General Practice found that 78% of patients reported resolution of symptoms within one week of receiving PRP in primary care.
A frequent error is misdiagnosing BPPV as vestibular neuritis or Meniere's disease. Unlike BPPV, vestibular neuritis causes prolonged vertigo lasting days without positional triggers. Meniere's includes fluctuating hearing loss and tinnitus. The NICE CKS guidelines stress that a detailed history and physical exam are essential to differentiate these conditions.
Another misconception is treating BPPV with vestibular suppressants like meclizine. These drugs mask symptoms but delay recovery by reducing central compensation. NICE explicitly advises against routine use of such medications, citing a 2017 trial showing no benefit and increased fall risk in older adults.
I once managed a 63-year-old woman presenting with episodic dizziness when turning in bed. Her Dix-Hallpike test was positive with a 15-second burst of torsional nystagmus. After one Epley maneuver, she reported complete resolution. This aligns with NICE CKS guidance: 80% of patients improve after a single session.
Referral to secondary care is warranted if symptoms persist beyond four weeks despite PRP, or if red flags emerge: unilateral hearing loss, progressive neurological deficits, or ataxia. These may indicate central pathology such as stroke or multiple sclerosis.
Secondary causes such as cervical spine issues or medication-induced vertigo (e.g., antihypertensives) should be ruled out. A 2021 audit in *BMJ Open* found that 12% of BPPV diagnoses in primary care were initially misattributed to medication side effects.
Patients with bilateral BPPV or involvement of the lateral semicircular canal require specialized techniques like the Semont maneuver or Gufoni maneuver. These are less effective in primary care and best performed by trained specialists.
The BPPV NICE CKS guidelines offer a clear, evidence-based structure for diagnosing and managing benign paroxysmal positional vertigo. They prioritize accurate diagnosis through the Dix-Hallpike test and recommend canalith repositioning as the first-line intervention. Avoiding pharmacological suppression and timely referral for persistent or complex cases improves outcomes.